id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-333684-j1sg46w9	Filippi, Federica	COVID‐19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy	2020-06-10		.txt	text/plain	795	44	46	About 750 psoriatic patients assuming biological therapy currently refer to our psoriasis outpatient service, in Sant'Orsola-Malpighi University Hospital, Bologna (Italy), with an average of 80 patients visited weekly. In the screening and monitoring of psoriatic patients, we follow the latest Italian guidelines 3 : blood tests (full blood count, creatinine and electrolytes, liver function tests, serum lipids, fasting glucose) as well as psoriasis disease severity assessment and general physical examination should be performed at baseline and periodically afterwards, on average every 3-4 months, based on clinical judgement, in particular extension of the disease (body surface area, nail involvement, critical areas localization), diagnosis of arthropatic psoriasis, comorbidities and other associated symptoms. Non-urgent blood tests were also suspended, including monitoring in psoriatic patients undergoing biological therapy 7 . If this is not so, it could be the starting point for a further lengthening of the monitoring time of psoriatic patients considered responders to biological therapy.	./cache/cord-333684-j1sg46w9.txt	./txt/cord-333684-j1sg46w9.txt